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What We Have To Do in Immunology and Virology
-OPINION-
Shingo Iwami a,b,c* , Kei Sato c
JST PRESTO a, Gmduate School of Mathematical Sciences, The University of Tokyo b,
Institute for Virus Research c
Mathematical modeling, which at one time was essentially ignored by the experimental
immunology and virology communities, has in the last 15 years become an important tool
to aid biology. In fact, almost all of the major scientific disciplines are now collaborating
with a theoretical immunologist, with the exception of Japan. This is because mathe-
matical modeling has provided several quantitative insights which cannot be obtained by
experimental and clinical studies alone, especially, in the fields of human specific infec-
tious disease such as HIV, HCV and influenza infection [Nature, 1995, 373, 117-122: X.
Wei et al. & 123-126: DD. Ho et al., PNAS, 1996, 93, 4398-4402: MA. Nowak, Science,
1998, 282, 103-107: AU. Neumann et al.]. Mathematical modeling is also improving our
understanding of lymphocyte dynamics and the quantitative events that underlie the im-
mune response to pathogens [Science, 1998, 279, 1223-1227: H. Mohri et al., JEM, 2001,
194, 1277-1287: H. Mohri et al., JV, 2006, 80, 7590-7599: P. Baccam et al., PNAS, 2008,
105, 6115-6120: N. Vrisekoop et al.].
Unfortunately, there are few research collaborations between immunologists, virolo-
gists and theorists in Japan. This is because theorists have not been trained in handling
mathematical models in the fields of immunology and virology, resulting in extremely
few opportunities for experimental researchers to associate with a modeling study. It is
essential to establish a unique and original environment in Japan for creating opportuni-
ties which are distinct from the American and European countries, in which experimental
researchers and theorists approach and cooperate with each other. These types of collab-
orations will provide us with novel insights in several immunological fields.
Our knowledge of immunology and virology is derived from various fields of study
(medicine $\Rightarrow$ chemistry $\Rightarrow$ cell biology $\Rightarrow$ molecular biology). Which study will help pio-
neer the next generation of exploration? We are now generating and obtaining enormous
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volumes of data more than ever before by using the know-how of current technology to
constantly develop higher throughput technology. However, the methods used to analyze
these enormous amounts of data are extremely limited and lag behind the pace at which
the data can be produced. “A Merger between Immunology, Virology and Mathemat-
ics“ is a new challenge for answering our future needs to analyze various time course
data mathematically, computationally and statistically, and is a key factor needed in the
current field of immunology. In fact, collaborating efforts in immunology, virology and
mathematics recently enabled us to analyze many complex immunological phenomena
including immune cell migration [Nature Rev. Immunol., 2009, 9, 789-798: JB. Beltman
et al.], immunologic memory, and interactions between virus and immune cells (one of my
PRESTO projects), amongst others.
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